Matthew W. Strobeck - 29 May 2026 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Reporting relationship: Director
Issuer ticker: QDEL
Reported as of: 29 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jun 2026, 16:11:11 UTC
Prior SEC filing: 13 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Phillip S. Askim, attorney-in-fact for Matthew W. Strobeck

Key filing fact

Matthew W. Strobeck filed Form 4 for QuidelOrtho Corp (QDEL) on 02 Jun 2026.

Key facts

This page summarizes Matthew W. Strobeck's Form 4 filing for QuidelOrtho Corp (QDEL).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Jun 2026, 16:11.

Change

Previous filing in this sequence was filed on 13 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001377832 Primary reporting owner

Strobeck Matthew

Relationship: Director
Address: 9975 SUMMERS RIDGE ROAD, SAN DIEGO
Signature: /s/ Phillip S. Askim, attorney-in-fact for Matthew W. Strobeck
Signature date: 02 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QDEL transaction

Common Stock

Award

Transaction value
Shares: +6,829
Change %: +25%
Price: $0.000000^*
Shares after: 34,604
Date: 29 May 2026
Ownership: Direct
Footnotes: F1

QDEL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 16,630
Date: 29 May 2026
Ownership: UGMA Account
Footnotes: F2

QDEL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 38,145
Date: 29 May 2026
Ownership: Birchview
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Restricted Stock Units (Equity Grant)

Options Exercise

Transaction value
Shares: -6,829
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,829
Exercise price
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Reflects release of restricted stock units that were previously reported on a Form 4.

Footnote F2

The Reporting Person is custodian under the Uniform Gift to Minor Act of 16,630 shares held by four of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F3

The Reporting Person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC in his capacity as the Managing Partner of such entity. The Reporting Person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F4

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

Footnote F5

The restricted stock units vested on May 29, 2026.